CADENCE PHARMACEUTICALS INC Contracts & Agreements

SETTLEMENT AGREEMENT (Filed With SEC on February 28, 2014)

AGREEMENT AND PLAN OF MERGER AMONG MALLINCKRODT PUBLICLIMITED COMPANY, MADISON MERGER SUB, INC. and CADENCE PHARMACEUTICALS,INC. Dated as of February 10, 2014 (Filed With SEC on February 11, 2014)

CADENCE PHARMACEUTICALS, INC. BONUS PLAN EffectiveJanuary 1, 2014 (Filed With SEC on November 26, 2013)

AMENDED AND RESTATED CADENCE PHARMACEUTICALS, INC. DIRECTOR COMPENSATION POLICY Effective November 21, 2013 (Filed With SEC on November 26, 2013)

THIRD AMENDMENT TO LEASE (High Bluff Ridge) (Filed With SEC on September 27, 2013)

AMENDED AND RESTATED CADENCE PHARMACEUTICALS, INC. DIRECTOR COMPENSATION POLICY Effective March 13, 2013 (Filed With SEC on August 2, 2013)

SETTLEMENT AND TERMINATION AGREEMENT (Filed With SEC on May 3, 2013)

MANUFACTURING AND SUPPLY AGREEMENT dated as of March 4, 2013 by and between Laboratorios Grifols, S.A. and Cadence Pharmaceuticals, Inc. TABLE OF CONTENTS (Filed With SEC on May 3, 2013)

CADENCE PHARMACEUTICALS, INC. BONUS PLAN Effective January 1, 2013 (Filed With SEC on March 8, 2013)

CADENCE PHARMACEUTICALS, INC. EXECUTIVE SEVERANCE PLAN (AND SUMMARY PLAN DESCRIPTION) (Filed With SEC on March 8, 2013)

WAIVER, CONSENT AND OPTION TERMINATION AGREEMENT (Filed With SEC on March 8, 2013)

SETTLEMENT AGREEMENT (Filed With SEC on March 8, 2013)

LICENSE AGREEMENT (Filed With SEC on March 8, 2013)

AMENDED AND RESTATED SUPPLY AGREEMENT between LAWRENCE LABORATORIES, an operating division of Swords Laboratories and CADENCE PHARMACEUTICALS, INC. effective as of February 22,... (Filed With SEC on February 28, 2013)

WARRANT TO PURCHASE STOCK (Filed With SEC on December 6, 2012)

FIRST AMENDMENT TO SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (Filed With SEC on December 6, 2012)

CADENCE PHARMACEUTICALS, INC. BONUS PLAN Effective January 1, 2012 (Filed With SEC on March 13, 2012)

FIRST AMENDMENT TO LEASE (High Bluff Ridge) (Filed With SEC on March 13, 2012)

SECOND AMENDMENT TO LEASE (High Bluff Ridge) (Filed With SEC on March 13, 2012)

WARRANT TO PURCHASE STOCK (Filed With SEC on December 27, 2011)

SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (Filed With SEC on December 27, 2011)

CADENCE PHARMACEUTICALS, INC. (a Delaware corporation) 19,000,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on November 16, 2011)

AMENDED AND RESTATED CADENCE PHARMACEUTICALS, INC. DIRECTOR COMPENSATION POLICY Effective September 1, 2011 (Filed With SEC on November 4, 2011)

CADENCE PHARMACEUTICALS, INC. AMENDED AND RESTATED BONUS PLAN Effective January 1, 2011 (Filed With SEC on May 5, 2011)

Cadence Pharmaceuticals, Inc. Bonus Plan Effective January 1, 2011 (Filed With SEC on March 4, 2011)

Confidential AMENDED & RESTATED DEVELOPMENT AND SUPPLY AGREEMENT By and Between CADENCE PHARMACEUTICALS, INC. and BAXTER HEALTHCARE CORPORATION (Filed With SEC on February 2, 2011)

SUPPLY AGREEMENT between LAWRENCE LABORATORIES and CADENCE PHARMACEUTICALS, INC. effective as of December 1, 2010 i TABLE OF CONTENTS (Filed With SEC on December 2, 2010)

FIRST AMENDMENT TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (Filed With SEC on November 26, 2010)

CADENCE PHARMACEUTICALS, INC. (a Delaware corporation) 11,500,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on November 16, 2010)

OPTION AGREEMENT (Filed With SEC on August 6, 2010)

WARRANT TO PURCHASE STOCK (Filed With SEC on June 21, 2010)

AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (Filed With SEC on June 21, 2010)

CADENCE PHARMACEUTICALS, INC. BONUS PLAN Effective January 1, 2010 (Filed With SEC on March 15, 2010)

CADENCE PHARMACEUTICALS, INC. 2006 EQUITY INCENTIVE AWARD PLAN (Filed With SEC on September 2, 2009)

EMPLOYMENT AGREEMENT (Filed With SEC on June 22, 2009)

[SECOND] AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 16, 2009)

CADENCE PHARMACEUTICALS, INC. BONUS PLAN (Filed With SEC on March 16, 2009)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 20, 2009)

WARRANT TO PURCHASE SHARES OF COMMON STOCK OF CADENCE PHARMACEUTICALS, INC. (Filed With SEC on February 20, 2009)

If to Solvay: SOLVAY SA Attention to: General Manager Solvay Peptides, (Filed With SEC on December 5, 2008)

EXHIBIT A POSSIBLE SECONDARY SOURCES (Filed With SEC on December 5, 2008)

SECOND AMENDED AND RESTATED CADENCE PHARMACEUTICALS, INC. (Filed With SEC on November 7, 2008)

CADENCE PHARMACEUTICALS, INC. BONUS PLAN Effective January 1, 2008 Revised March 18, 2008 Revisions Effective January 1, 2008 (Filed With SEC on May 9, 2008)

AMENDMENT NO. 2 TO COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on May 9, 2008)

Acetavance. We are developing Acetavance in the U.S. market for the treatment of acute pain and fever. According to IMS Health, Inc., or IMS, an independent marketing research... (Filed With SEC on March 13, 2008)

Entry Into a Material Definitive Agreement (Filed With SEC on February 15, 2008)

Description of Exhibit (Filed With SEC on December 3, 2007)

Current assets (Filed With SEC on November 14, 2007)

DEVELOPMENT AND SUPPLY AGREEMENT By and Between CADENCE PHARMACEUTICALS, INC. and BAXTER HEALTHCARE CORPORATION (Filed With SEC on July 23, 2007)

Pro Forma (Filed With SEC on November 30, 2006)

IV APAP for the Treatment of Acute Pain and Fever (Filed With SEC on October 10, 2006)

IV APAP for the Treatment of Acute Pain and Fever (Filed With SEC on September 25, 2006)

IV APAP for the Treatment of Acute Pain and Fever (Filed With SEC on August 30, 2006)

IV APAP for the Treatment of Acute Pain (Filed With SEC on July 17, 2006)

Category

Industry

Companies

Contracts

CADENCE PHARMACEUTICALS INC Contracts & Agreements